The gastrointestinal side effects of GLP-1 agentsparticularly vomiting and diarrheacan lead to depletion of essential electrolytes including sodium, magnesium, potassium, and calcium, all of which are critical for normal muscle contraction and relaxation
Semaglutide remains an important option for many patients, both as a GLP-1 receptor agonist with the longest established safety record in the class and as an agent with robust cardiovascular outcome data from the SELECT trial
Converting doses to syringe units This is where many researchers make critical errors
Glucagon suppression under GLP-1RA therapy: hidden trade-offs for muscle and resilience
While some strains of bacteria can directly promote the production of GLP-1
3 Introduction/background: a novel dual incretin analog Despite historical research stating GIP did not assist in lowering blood glucose even with supratherapeutic levels, the success of GLP-1 RAs has led to the approval of a novel GLP-1/GIP RA, tirzepatide [42]
